-
Polatuzumab vedotin, sold
under the
brand name
Polivy, is a CD79b-directed antibody-drug
conjugate medication used for the
treatment of
diffuse large B-cell...
- eating. It was
coined the "what-the-****"
effect by
dieting researcher Janet Polivy in 2010. She
describes this
effect as the type of
thinking which says, "What...
-
treatment of
influenza A and
influenza B.
Developed by Shionogi. 2019:
Polivy (Polatuzumab vedotin-piiq):
Treatment of
diffuse large B-cell
lymphoma when...
-
American Cancer Society. 2019.
Retrieved 23
August 2019. "With hard-fought
Polivy approval,
Roche looks to
shake up
decades of
established practice in lymphoma"...
-
Perjeta (pertuzumab), for HER-2
positive breast cancer.
Polatuzumab vedotin|
Polivy (polatuzumab vedotin), for
diffuse large B-cell lymphoma.
Protropin (somatrem)...
- no
other special responsibilities. The
mayor as of
October 2024 is
David Polivy, who
previously served in that role from 2019
through 2022, and who is currently...
- 9 (4): 279–84. doi:10.1007/BF03325082. PMID 15844400. S2CID 13089418.
Polivy J,
Herman CP (2002). "Causes of
eating disorders".
Annual Review of Psychology...
-
Eating Behaviors. 21: 11–7. doi:10.1016/j.eatbeh.2015.12.006. PMID 26724459.
Polivy, Janet; Herman, C.
Peter (February 2002). "Causes of
Eating Disorders"....
- CD22-positive B-cell
precursor acute lymphoblastic leukemia Polatuzumab vedotin Polivy Genentech,
Roche relapsed or
refractory diffuse large B-cell
lymphoma (DLBCL)...
- 1007/s13679-016-0192-0. hdl:20.500.11794/13474. PMID 26820622. S2CID 207474222.
Polivy,
Janet (December 2017). "What's that you're eating?
Social comparison and...
